Xu K - Search Results

1

Multienzyme-Mimicking LaCoO₃ Nanotrigger for Programming Cancer-Cell Pyroptosis.

Xu K, Chang M, Wang Z, Yang H, Jia Y, Xu W, Zhao B, Chen Y, Yao F. Xu K, et al. Among authors: xu w. Adv Mater. 2023 Sep;35(35):e2302961. doi: 10.1002/adma.202302961. Epub 2023 Jul 14. Adv Mater. 2023. PMID: 37227938

2

Intrinsic mechanism and pharmacologic treatments of noise-induced hearing loss.

Xu K, Xu B, Gu J, Wang X, Yu D, Chen Y. Xu K, et al. Among authors: xu b. Theranostics. 2023 Jun 19;13(11):3524-3549. doi: 10.7150/thno.83383. eCollection 2023. Theranostics. 2023. PMID: 37441605 Free PMC article. Review.

3

Gelatin-Encapsulated Tetrahedral DNA Nanostructure Enhances Cellular Internalization for Treating Noise-Induced Hearing Loss.

Xu K, Du Y, Xu B, Huang Y, Feng W, Yu D, Chen Y, Wang X. Xu K, et al. Among authors: xu b. Small. 2024 Jun;20(26):e2310604. doi: 10.1002/smll.202310604. Epub 2024 Feb 8. Small. 2024. PMID: 38329190

4

Ototoxicity-Alleviating and Cytoprotective Allomelanin Nanomedicine for Efficient Sensorineural Hearing Loss Treatment.

Chen F, Jiang Q, Xu B, Huang Y, Xu K, Xu X, Yu D, Chen Y, Wang X. Chen F, et al. Among authors: xu k, xu b, xu x. ACS Nano. 2024 Sep 11. doi: 10.1021/acsnano.4c10610. Online ahead of print. ACS Nano. 2024. PMID: 39259947

5

Alpha- and gamma-mangostins exhibit anti-acne activities via multiple mechanisms.

Xu N, Deng W, He G, Gan X, Gao S, Chen Y, Gao Y, Xu K, Qi J, Lin H, Shen L, Li X, Hu Z. Xu N, et al. Among authors: xu k. Immunopharmacol Immunotoxicol. 2018 Oct;40(5):415-422. doi: 10.1080/08923973.2018.1519831. Epub 2018 Nov 13. Immunopharmacol Immunotoxicol. 2018. PMID: 30422030

6

Zhang H, Sun C, Chen Y, Yuan Y, Xu K, Lu P, Wang J, Zhang N. Zhang H, et al. Among authors: xu k. J Oncol. 2022 Apr 23;2022:2607829. doi: 10.1155/2022/2607829. eCollection 2022. J Oncol. 2022. PMID: 35502200 Free PMC article.

7

Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects.

Xu S, Deng KQ, Lu C, Fu X, Zhu Q, Wan S, Zhang L, Huang Y, Nie L, Cai H, Wang Q, Zeng H, Zhang Y, Wang F, Ren H, Chen Y, Yan H, Xu K, Zhou L, Lu M, Zhu Y, Liu S, Lu Z. Xu S, et al. Among authors: xu k. Metabolism. 2024 Jun;155:155832. doi: 10.1016/j.metabol.2024.155832. Epub 2024 Mar 2. Metabolism. 2024. PMID: 38438106

8

An optimized high-throughput SARS-CoV-2 dual reporter trans-complementation system for antiviral screening in vitro and in vivo.

Li Y, Tan X, Deng J, Liu X, Liu Q, Zhang Z, Huang X, Shen C, Xu K, Zhou L, Chen Y. Li Y, et al. Among authors: xu k. Virol Sin. 2024 Jun;39(3):447-458. doi: 10.1016/j.virs.2024.03.009. Epub 2024 Mar 26. Virol Sin. 2024. PMID: 38548102 Free PMC article.

9

The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.

Zhang Z, Zhou L, Liu Q, Zheng Y, Tan X, Huang Z, Guo M, Wang X, Chen X, Liang S, Li W, Song K, Yan K, Li J, Li Q, Zhang Y, Yang S, Cai Z, Dai M, Xian Q, Shi ZL, Xu K, Lan K, Chen Y. Zhang Z, et al. Among authors: xu k. Emerg Microbes Infect. 2024 Dec;13(1):2353302. doi: 10.1080/22221751.2024.2353302. Epub 2024 May 26. Emerg Microbes Infect. 2024. PMID: 38753462 Free PMC article.

10

Artificial intelligence for predicting treatment responses in autoimmune rheumatic diseases: advancements, challenges, and future perspectives.

Yang Y, Liu Y, Chen Y, Luo D, Xu K, Zhang L. Yang Y, et al. Among authors: xu k. Front Immunol. 2024 Oct 22;15:1477130. doi: 10.3389/fimmu.2024.1477130. eCollection 2024. Front Immunol. 2024. PMID: 39502698 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,708 results

Search Page

Filters